Isolated delusional syndrome in Parkinson's Disease

Parkinsonism and Related Disorders

Volumn 16, Issue 8, 2010, Pages 550-552

  Stefanis, Nikos ^a,b   Bozi, Maria ^a   Christodoulou, Christos ^a   Douzenis, Athanassios ^a   Gasparinatos, Gerasimos ^a   Stamboulis, Eleftherios ^a   Stefanis, Costas ^b   Stefanis, Leonidas ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b University Research Institute of Psychiatry (EPIPSI)   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; AMANTADINE; APOMORPHINE; BENSERAZIDE PLUS LEVODOPA; CLONAZEPAM; ENTACAPONE; HALOPERIDOL; METHYLPREDNISOLONE; OLANZAPINE; PRAMIPEXOLE; QUETIAPINE; RASAGILINE; ROPINIROLE; ROTIGOTINE; SELEGILINE; ZIPRASIDONE;

ADULT; AGED; ALERTNESS; ARTICLE; BRADYKINESIA; CASE REPORT; DELUSION; DEMENTIA; DISEASE PREDISPOSITION; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSKINESIA; FEMALE; HUMAN; MALE; MUSCLE STIFFNESS; PARANOIA; PARKINSON DISEASE; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOPHRENIFORM DISORDER; TEMPORAL ARTERITIS; TREATMENT RESPONSE; TREMOR; VISUAL HALLUCINATION;

AGED; AMANTADINE; ANTIPARKINSON AGENTS; BENSERAZIDE; BENZOTHIAZOLES; CATECHOLS; CLONAZEPAM; FEMALE; HUMANS; INDANS; INDOLES; LEVODOPA; MALE; MIDDLE AGED; NITRILES; PARKINSON DISEASE; SCHIZOPHRENIA, PARANOID; SYNDROME;

EID: 77956175932     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2010.06.010     Document Type: Article

References (12)

1. Ravina B., Marder K., Fernandez H.H., Friedman J.H., McDonald W., Murphy D., et al. Diagnostic criteria for psychosis in Parkinson's Disease. Report of an NINDS, NIMH work group. Movement Disord 2007, 22:1061-1068.
2. Fenelon G. Psychosis in Parkinson's Disease: phenomenology, frequency, risk factors, and current understanding of pathophysiologic mechanisms. CNS Spectr 2008, 13(3 Suppl. 4):18-25.
3. Gelb J., Oliver E., Gilman S. Diagnostic criteria for Parkinson's Disease. Arch Neurol 1999, 56(1):33-39.
4. Wolters E.C. Intrinsic and extrinsic psychosis in Parkinson's disease. J Neurol 2001, 248(suppl. 3):22-27.
5. Holroyd S., Currie L., Wooten G.F. Prospective study of hallucinations and delusions in Parkinson's Disease. J Neurol Neurosurg Psychiatry 2001, 70(6):734-738.
6. Marsh L., Williams J.R., Rocco M., Grill S., Munro C., Dawson T.M. Psychiatric comorbidities in patients with Parkinson disease and psychosis. Neurology 2004, 63(2):293-300.
7. Kiziltan G., ôzekmekçi S., Ertan S., Ertan T., Erginöz E. Relationship between age and subtypes of psychotic symptoms in Parkinson's disease. J Neurol 2007, 254(4):448-452.
8. Sato M., Numachi Y., Hamamura T. Relapse of paranoid psychotic state in methamphetamine model of schizophrenia. Schizophr Bull 1992, 18(1):115-122.
9. Murray R.M., Lappin J., Di Forti M. Schizophrenia: from developmental deviance to dopamine dysregulation. Eur Neuropsychopharmacol 2008, 18(Suppl. 3):S129-S134.
10. van Os J., Bak M., Hanssen M., Bijl R.V., de Graaf R., Verdoux H. Cannabis use and psychosis: a longitudinal population-based study. Am J Epidemiol 2002, 156(4):319-327.
11. Caspi A., Moffitt T.E., Cannon M., McClay J., Murray R., Harrington H., et al. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction. Biol Psychiatry 2005, 57(10):1117-1127.
12. van Winkel R., Stefanis N.C., Myin-Germeys I. Psychosocial stress and psychosis. A review of the neurobiological mechanisms and the evidence for gene-stress interaction. Schizophr Bull 2008, 34(6):1095-1105.